BTK and Venetoclax: A Comparison

Grant, just looking at this one, if you were to take the progression for your overall survival curves from BTK alone and Venetoclax of Benetuzumab, how would it be compared to the lines? I mean, all the caveats of indirect, but just that it gloped grossly. It looks kind of looks to me like a kind of be around the same place, but you tell me. Yeah. And no, I agree. So historically well, we see in continuation BTK inhibitors, maybe the PFS is a little bit better. But again, outcomes are still so good in your off of therapy. There's a lot of these benefits that as of right